Sebusa, Anecia .
HRN: 22-57-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
CLARITHROMYCIN 500MG (CAP)
02/06/2023
02/15/2023
PO
500 Mg
Bid
H. Pylori Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes